Stryker Corporation (0R2S)
LSE
Closed
Aug 24, 2026
Day's Range
318.3352 wk Range
281.04Overview - 0R2S - Stryker Corporation
Key Statistics
Valuation
Enterprise Value
138.75B
P/E (Trailing)
‪0.62‬
PEG Ratio
‪-0.09‬
Price / Sales (TTM)
‪1,766.31‬
Price / Book
‪5.29‬
EV / EBITDA
‪18.81‬
Profitability
Gross Margin
‪16.81%‬
Profit Margin
‪14.43%‬
Operating Margin
‪27.01%‬
Return on Assets
‪8.16%‬
Return on Equity
‪16.50%‬
Ownership
Shares Outstanding
374.18M
Float
347.78M
Held by Insiders
‪5.36%‬
Held by Institutions
‪82.76%‬
Price stats
Beta
‪0.77‬
50-Day Avg
‪332.59‬
200-Day Avg
‪296.34‬
Dividends
Frequency
Quarterly
Market Cap - 0R2S - Stryker Corporation
Peers - 0R2S - Stryker Corporation
Peer Comparison
Compared with companies in Medical Devices listed on LSE.
Profile Summary - 0R2S - Stryker Corporation
About
Stryker Corporation is a medical technology company that develops and markets products used in hospitals, surgery centers, and other healthcare settings. Its current portfolio spans MedSurg, Neurotechnology, and Orthopaedics, with offerings that include surgical equipment, endoscopy systems, patient handling and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
